We are live on ! Find out more
ICM

ISZO Capital Management Portfolio holdings

AUM $2M
1-Year Est. Return 35.61%
This Fund
S&P 500
This Quarter Est. Return
+24.67%
1 Year Est. Return
+35.61%
3 Year Est. Return
+68.24%
5 Year Est. Return
+471.73%
10 Year Est. Return
–
AUM
$69.5M
AUM Growth
-$6.09M
Cap. Flow
-$18.5M
Cap. Flow %
-26.58%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
3
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NTP
Nam Tai Property Inc.
NTP
+$11M
2
XPEL icon
XPEL
XPEL
+$5.21M
3
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$1.84M
4
FBRX icon
Forte Biosciences
FBRX
+$375K

Sector Composition

Rank Sector Weight
1 Healthcare 46.59%
2 Real Estate 31.83%
3 Consumer Discretionary 21.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDMO
1
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$32.4M 46.59%
4,220,148
-314,546
-7% -$1.84M
NTP
2
DELISTED
Nam Tai Property Inc.
NTP
$22.1M 31.83%
2,568,170
-1,250,000
-33% -$11M
XPEL icon
3
XPEL
XPEL
$1.4B
$15M 21.59%
1,023,699
-399,694
-28% -$5.21M
FBRX icon
4
Forte Biosciences
FBRX
$1.63B
– –
-1,509
Closed -$375K

Similar funds

LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

ISZO Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, ISZO Capital Management held 4 positions worth $69.5M, down 8.1% from $75.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ISZO Capital Management withdrew a net $18.5M in Q4 2019, closing 1 position and reducing 3 holdings. Its most notable exit was Forte Biosciences, an estimated $375K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 32% a quarter earlier, followed by Real Estate and Consumer Discretionary.

  • ISZO Capital Management's biggest Q4 2019 reduction was Nam Tai Property Inc., cutting an estimated $11M.
  • ISZO Capital Management fully exited Forte Biosciences in Q4 2019, selling an estimated $375K.
  • ISZO Capital Management's ten largest holdings make up 100% of its $69.5M portfolio in Q4 2019.
  • ISZO Capital Management opened 0 new positions and closed 1 in Q4 2019.
  • ISZO Capital Management's portfolio value fell 8.1% quarter-over-quarter to $69.5M.

Based on ISZO Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.